The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Editorial

Sunday, 07 July 2013
Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated, despite clear evidence-based guidelines for identification and management, and the availability of low-cost, generic, high-intensity statin treatment. Genetic cascade testing is the key to early diagnosis, which can help ensure that this treatment is no longer 'too little, too late'. HEART UK - The Cholesterol Charity - has provided editorial support and review of this sponsored FH series.This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
Category: Editorial
Sunday, 07 July 2013
In this paper, we summarise previously reported findings from the MY-WAIST study, which aimed to evaluate a primary care strategy for identifying people with undiagnosed type 2 diabetes or at increased risk of developing this condition. Recruitment was unexpectedly low, but the qualitative data collected, including interviews with healthcare providers, helped to highlight some of the reasons for poor uptake of the appointments offered. Perceived barriers to recruitment included heavy workloads and competing demands in primary care. Lower uptake in people from harder-to-reach groups was identified in our quantitative findings and was also suggested by healthcare providers' perceptions about the characteristics of patients who attended.
Category: Editorial
Sunday, 07 July 2013
Successful management of individuals with diabetes, or any other single component of the metabolic syndrome, requires treatment of all the related physiological systems as a whole. This treatment must be underpinned by the management of obesity, and drugs should be preferred that address the entire portfolio of the metabolic syndrome.
Category: Editorial
Sunday, 07 July 2013
This study shows that people living in London have better treatment rates with lipid lowering drugs than the general population. This observation may be explained in part by the fact that London is a highly mobile population, so new patient checks are more common.
Category: Editorial
Sunday, 07 July 2013
"I like to think of medicine in our day as an ever-broadening and deepening river, fed by the limpid streams of pure science- Christian A. Herter (1865-1910), US neurologist, New York.
Category: Editorial
Sunday, 07 July 2013
The NHS Health Check offers 15 million people aged 40-74 in England an assessment of cardiovascular risk, together with preventive interventions, once every five years. This national programme has aroused some controversy, but there is an urgent need to takeaction now to reduce the toll in England of preventable, premature death and disability caused by cardiovascular disease.
Category: Editorial
Sunday, 07 July 2013
The long-awaited Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3) have been published nine years after publication of JBS2, which caused a furore and much debate about lipid targets of 4.00 mmol/l and 2.00 mmol/l that were subsequently endorsed by NICE. So what are the most important new recommendations from JBS3, and what will they mean for our patients and our clinical practice?
Category: Editorial
Sunday, 07 July 2013
GPs, practice nurses and other primary healthcare professionals are now at the frontline of managing cardiovascular disease (CVD) and delivering preventive care. The aim of this study was to explore clinicians' experiences and their views on the factors that influence their ability to fulfilthis demanding role. GPs and other primary healthcare professionals expressed similar views. In particular, they reported a sense of pressure and disempowerment, and voiced concerns about the ability of general practice to take on its greater role in reducing the burden of CVD.
Category: Editorial

Article search and filter